Jiang SH, Roberts DM, Clayton PA, Jardine M. Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol. 2013;45(5):1423-8.

Grace B, Clayton P, Cass A, McDonald S. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney International. 2013;83(1):138-45.

Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study. Perit Dial Int. 2013;33(1):75-85.

Thirugnanasambathan T, Hawley C, Badve S, McDonald S, Brown F, Boudville N, et al. Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis. 2012;59(1):84-91.

Tang W, Mohandas J, McDonald S, Hawley C, Badve S, Boudville N, et al. End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA Registry cases. BMC Nephrology. 2012;13(164):1-11.

Ritchie AG, Clayton PA, MacKie FE, Kennedy SE. Nationwide survey of adolescents and young adults with end-stage kidney disease. Nephrology. 2012;17(6):539-44.

Lim W, Dogra G, Chadban S, Campbell S, Clayton P, Cohney S, et al. Lack of impact of donor age on patient survival for renal transplant recipients ≥ 60 years. Transpl Int. 2012;25(4):401-8.

Lim W, Clayton P, Wong G, Dogra G, Budgeon C, Murray K, et al. Association between initial and pretransplant dialysis modality and graft and patient outcomes in live- and deceased-donor renal transplant recipients. Transpl Int. 2012;25(10):1032-40.

Lim W, Chadban S, Clayton P, Budgeon C, Murray K, Campbell S, et al. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clinical Transplantation. 2012;26(4):428-37.

Johnson D, Clayton P, Cho Y, Badve S, Hawley C, McDonald S, et al. Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. Perit Dial Int. 2012;32(5):516-24.

Grace B, Clayton P, McDonald S. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrology. 2012;17(1):76-84.

Grace B, Clayton P, Cass A, McDonald S. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrology Dialysis Transplantation. 2012;27(11):4173-80.

Clayton P, McDonald S, Chapman J, Chadban S. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial. Transplantation. 2012;94(2):152-8.

Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrology. 2012;13(1):1-9.

Cho Y, Badva S, Hawley C, McDonald S, Brown F, Boudville N, et al. Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study. Nephrology Dialysis Transplantation. 2012;27(5):2028-36.

Chan H, Clayton P, McDonald S, Agar J, Jose M. Risk factors for dialysis withdrawal: An analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. American Society of Nephrology Clinical Journal. 2012;7(5):775-81.

Boudville N, Kemp A, Clayton P, Lim W, Badve S, Hawley C, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398-405.

Clayton P, McDonald S, Chadban S. Steroids and recurrent IgA nephropathy after kidney transplantation. American Journal of Transplantation. 2011;11(8):1645-9.

Bose B, McDonald S, Hawley C, Brown F, Badve S, Wiggins K, et al. Effect of dialysis modality on survival of hepatitis C-infected ESRF patients. American Society of Nephrology Clinical Journal. 2011;6(11):2657-61.

Yew CT, Talaulikar GS, Falk MC, Clayton P, Drozario J, Brown M. Acute interstitial nephritis secondary to deferasirox causing acute renal injury needing short-term dialysis. Nephrology. 2010;15(3):377.

Jiang SHT, Clayton PA, Maguire A, Talaulikar GS. Validation of the measurement of haemodialysis access flow using a haemoglobin dilution test. Blood Purif. 2011;32(1):48-52.

Clayton P, Singer R. 25-Hydroxyvitamin D levels in prevalent Australian dialysis patients. Nephrology. 2009;14(6):554-9.